Taste changes and eating habits on weight loss drugs
Part of Hormones & metabolism clinical trials.
This study looks at how GLP-1 medications (like semaglutide/Wegovy or tirzepatide/Mounjaro) change your sense of taste and eating habits while losing weight. If you are 18–60, have obesity, and have been taking one of these drugs for at least 12 weeks, you may qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old
- You have been diagnosed with obesity
- You are taking a GLP-1 medication (like semaglutide/Wegovy/Ozempic or tirzepatide/Mounjaro)
- You have been on this medication for at least 12 weeks
- Your clinic has your diet and treatment records from that time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
This trial compares different ways to keep weight off after you've lost weight using a GLP-1 medication, like semaglutide or tirzepatide. It tests reducing your GLP-1 dose and adding other weight loss medications to help maintain your progress.
This trial tests a new way to deliver semaglutide through a strip placed on the tongue for weight loss in adults with obesity. It may help you lose weight without a needle.
This study tests whether a weight-loss medication (a GLP-1 agonist) can change how the brain works and help with long-term weight control. It involves brain scans and a closely monitored treatment plan.
This study compares how a GLP-1 medication (a drug that helps control blood sugar and weight) changes the way your body stores and uses fat. Researchers will use imaging scans to see these changes over time in people with metabolic syndrome—a cluster of health conditions including high blood pressure, high cholesterol, and excess weight.
This study looks at how weight-loss medications (GLP-1 drugs) might affect your saliva and teeth. If you're starting one of these medications, the study will check your mouth health before you start and again after 3 months.
Hear when a new Obesity & Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.